MedWatch

Life science executives: We can feel the lack of traveling salespeople

Novo Nordisk and Coloplast have both experienced the necessity of salespeople pitching products in person, whereas Teva's Kåre Schultz highlights differences in the markets.

Photo: Stine Bidstrup/ERH

Although virtual meetings have become more widespread, also when selling medicine, Danish pharmaceutical company Novo Nordisk's experience with launching diabetes tablet Rybelsus has shown that they are not sufficient, according to Danish newspaper Børsen.

Novo Nordisk CEO & President Lars Fruergaard Jørgensen is dubious about the notion that physical salespeople might be replaced by digital communications with physicians.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs